Browse CATs

Browse CATs  internal medicine  gastroenterology  inflammatory bowel disease

Diagnosis Harm/ aetiology Prognosis Therapy Relapse  - Crohn's disease  - Ulcerative colitis Remission

Crohn's disease IL-10 increases remission rates in mild to moderately active cases but adverse effects are common Level of evidence 1b Expiry Date October 2003 Crohn's disease budesonide promotes remission in active disease less effectively than conventional steroids but does not prevent relapse Level of evidence 1a Expiry Date October 2003 Crohn's disease steroids helped induce remission in active disease. Level of evidence 1b Expiry Date May 2003 Crohn's disease steroids are better than enteral nutrition in inducing remission in active disease. Level of evidence 1a Expiry Date May 2003 Crohn's disease antimetabolites induce remission in active disease. Level of evidence 1a Expiry Date May 2003 Crohn's disease cyclosporine helped improve chronic active disease resistant to steroids. Level of evidence 1b Expiry Date May 2003 Crohn's disease enteral nutrition is worse than steroids are inducing remission. Level of evidence 1a Expiry Date May 2003 Crohn's disease no benefit from anti-tuberculous chemotherapy. Level of evidence 1b Expiry Date May 2003 Crohn's disease budesonide was more likely to induce remission than mesalamine. Level of evidence 1b Expiry Date May 2003 Crohn's disease an infusion TNF-alpha antibodies improves symptoms and chance of remission in active disease Level of evidence 1b Expiry Date May 2003 Crohn's disease budesonide was less effective but less toxic than prednisolone in active disease. Level of evidence 1b Expiry Date May 2003 Crohn's disease metronidazole reduced disease activity in active disease. Level of evidence 1b Expiry Date May 2003 Crohn's disease adding sulphasalazine to steroids did not increase remission of active disease. Level of evidence 1b Expiry Date May 2003 Crohn's disease unclear role for metronidazole and ciprofloxacin in treating active disease. Level of evidence 1b- Expiry Date May 2003 Crohn's disease methotrexate increased remission rates in chronic active disease. Level of evidence 2b Expiry Date May 2003 Crohn's disease mesalamine led to more cases of remission in active disease. Level of evidence 2b Expiry Date May 2003 Crohn's disease budesonide helped induce remission in patients with active disease. Level of evidence 1b Expiry Date May 2003 Crohn's disease, ulcerative colitis no clear role for vancomycin. Level of evidence 1b- Expiry Date May 2003 Ulcerative colitis / Crohn's disease no clear role for bowel rest. Level of evidence 1b- Expiry Date May 2003 Crohn's disease, ulcerative colitis toxic megacolon may be decompressed medically. Level of evidence 4 Expiry Date May 2003